A project costing nearly R$3 billion will launch a 30 m² 100% electric factory in Ireland, featuring 600 solar panels, heat pumps, and the promise of leading the global production of glucose sensors – CPG Click Petróleo e Gás

Construction
On November 18, 2024, Abbott opened a new 30-square-meter factory in Kilkenny, Ireland, dedicated to the production of FreeStyle Libre 3 sensors, used for continuous glucose monitoring by people with diabetes.
According to the company, the unit is part of an investment package of €440 million in the country, divided between Kilkenny and an expansion in Donegal, and was designed to operate in a way fully electric, using heat pumps and solar panels installed on the roof.
According to Abbott, the project is linked to expanding industrial capacity to meet the growing global demand for continuous glucose monitoring devices.
How much does it cost to enclose a low-cost house with white aluminum windows versus painted steel windows: a real comparison of prices, installation, maintenance, and thermal-acoustic comfort.
The government is launching houses made of recycled plastic that can be completed in up to five days, have two bedrooms, use interlocking blocks, and generate income for waste pickers while tackling waste and the housing deficit.
The government is launching a project to expand the coastline of the neighboring city, the largest beach widening project in the country, with 1,1 million m³ of sand, new erosion control structures, and comprehensive urban improvements.
Ponte dos Vales project born after the 2024 flood: a 3,1 km elevated crossing between Cruzeiro do Sul and Estrela, a safe alternative route between BR386 and RS287, R$ 288 million, delivery in 2027.
In its institutional statement, the company affirms that the Kilkenny plant was planned as a global center of excellence in manufacturing for the diabetes care business and that it is expected to concentrate the world’s largest production of sensors from the FreeStyle Libre line.
The new unit is directly associated with the FreeStyle Libre 3, presented by Abbott as the latest version of its continuous glucose monitoring system.
In the material released during the inauguration, the company describes the Libre 3 as “the world’s smallest sensor”, reinforcing the product’s technical attributes within a portfolio that, according to corporate data, is already used by more than 6 million people em more than 60 countries.
Despite highlighting the expansion of production capacity, Abbott has not released public estimates on annual production volumes, detailed industrial ramp-up timelines, or a list of markets that will be supplied from Ireland.
Nevertheless, by stating that the plant will have the largest global production of the Libre line, the company indicated that Kilkenny will occupy a central role in the international supply chain of the product.
According to the company, the factory is expected to employ more than 800 people.
The inauguration ceremony brought together Abbott executives and Irish authorities, including Taoiseach Simon Harris and the company’s CEO, Robert Ford.
The government’s participation was presented as part of the recognition of the economic impact of the investment.
The state agency IDA Ireland, responsible for attracting foreign investment, highlighted in the announcement that this is Abbott’s tenth unit in the country.
According to the company, the Irish operation comprises approximately 6.000+ employees distributed in 10 websites, with activities in different regions.
In addition to the new factory in Kilkenny, Abbott reported that the €440 million package includes an expansion in Donegal, with the expectation of creating approximately 200 jobs.
The company did not detail how much of the total investment was allocated to each location, nor did it present public export targets specifically linked to the new plant.
The character “100% electric” The factory’s design was presented by Abbott as part of the project’s engineering concept.
According to the company, the unit was built “with sustainability in mind” and operates entirely on electricity, based on six heat pumps of the air-to-water type.
The company also reported the installation of approximately 600 solar panels on the roof of the building.
According to the statement, the complex also has reservoirs for collecting rainwater, which is used in the plant’s internal processes.
These elements were described as part of the project’s infrastructure, without the disclosure of detailed quantitative indicators.
For example, information was not provided on the installed capacity of the photovoltaic system, the fraction of total consumption supplied by solar generation, the estimated annual energy consumption, nor data on electrical redundancy or emergency generation.
The information available so far is limited to what has been officially released by Abbott and reported by media outlets.
The adoption of a fully electric model in an industrial plant often attracts attention because manufacturing processes generally concentrate a large part of their energy consumption on air conditioning, water heating, and environmental control.
Industry experts point out that this type of infrastructure is particularly relevant in environments that require strict temperature and humidity control, such as those related to the production of medical devices.
In the specific case of Kilkenny, Abbott has not made a complete technical report of the project publicly available.
Based on the information released, it is known that the company opted for air-to-water heat pumps as the central element of the system, combined with rooftop solar power generation and water reuse.
Currently, there is insufficient public data to assess the unit’s detailed energy performance or its long-term operational indicators.
The factory’s opening comes at a time of expansion in the global market for diabetes technologies and continuous glucose monitoring.
Specialized reports highlighted the opening of the unit as part of Abbott’s strategy to expand the production capacity of the Libre 3, in a scenario of increasing adoption of this type of device.
The Irish Times newspaper described the Kilkenny plant as the world’s largest production center for these sensors.
Abbott, in its statements, directly linked the investment to the need to meet growing international demand, without specifying which regions will be prioritized for supply from Ireland.
Irish authorities treated the investment as strengthening the country’s position in the areas of healthcare and advanced manufacturing.
In the material released by Abbott, Simon Harris linked the new unit to the company’s historical presence in Ireland and the relevance of the medical technology sector to the local economy.
IDA Ireland also linked the project to a strategy of decentralizing jobs, focusing on attracting investment to regions outside major urban centers, such as Kilkenny.
This approach appears frequently in official announcements, alongside data on job creation and expansion of the industrial base.
At the same time, technical issues related to energy consumption, the autonomy of the electrical system, and specific efficiency targets remain without public detail, which limits more in-depth analyses of the operational scope of the adopted model.

Journalist graduated in 2017 and working in the field since 2015, with six years of experience in print magazines, stints on broadcast television channels, and over 12 online publications. He specializes in politics, employment, economics, courses, and other topics, and is also the editor of the CPG portal. Professional registration number: 0087134/SP. If you have any questions, want to report an error, or suggest a story on the topics covered on the website, please contact us at alisson.hficher@outlook.com. We do not accept resumes!
© 2025 Click Oil and Gas – All rights reserved

source

This entry was posted in Renewables. Bookmark the permalink.

Leave a Reply